- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Hospital Infanta Cristina Badajoz, Badajoz_Extremadura, Spain
- Hospital del Mar Barcelona, Barcelona_ Cataluña, Spain
- Instituto Catalán de Oncología (ICO) Barcelona, Barcelona_Cataluña, Spain
- Hospital San Pedro de Alcántara Cáceres, Cáceres_Extremadura, Spain
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,646 public trials
848 recruiting studies
Lymphoma trial results
NCT00003883
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
- University of Washington Medical Center Seattle, Washington, United States
NCT00014391
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +107 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT01085058
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
Not specified
Completed
Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma
NCT00251394
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00301314
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
NCT00301288
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
NCT00301301
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
Completed
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
NCT00276003
- Conditions
- Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Lovelace Sandia Health Systems Dept of Hematology Albuquerque, New Mexico, United States
- University of New Mexico Albuquerque, New Mexico, United States
- Conditions
- Blood-Borne Infections, Communicable Diseases, Diffuse Large B Cell Lymphoma, +22 more
- Locations
-
- H. Son Llatzer Palma de Mallorca, Balearic Islands, Spain
- Germans Trias i Pujol Badalona, Barcelona, Spain
- H. Clínic i Provincial, Barcelona Barcelona, Spain
- H. Vall d'Hebron, Barcelona Barcelona, Spain